Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

OBJECTIVES: To compare the clinical and electrophysiological features of myasthenia gravis (MG) patients with (seropositive) or without (seronegative) antibodies to acetylcholine receptor. To investigate whether antibodies to muscle specific kinase (MuSK) and ryanodine receptor (RyR) are associated...

Bibliografske podrobnosti
Main Authors:	Nemoto, Y, Kuwabara, S, Misawa, S, Kawaguchi, N, Hattori, T, Takamori, M, Vincent, A
Format:	Journal article
Jezik:	English
Izdano:	2005

Podobne knjige/članki

Seronegative myasthenia gravis.
od: Vincent, A, et al.
Izdano: (2004)

SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS
od: Huda, S, et al.
Izdano: (2014)

Antibodies to AChRs in seronegative myasthenia gravis
od: Leite, M, et al.
Izdano: (2006)

Myasthenia gravis seronegative for acetylcholine receptor antibodies.
od: Vincent, A, et al.
Izdano: (2008)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
od: Courtney Townsel, et al.
Izdano: (2016-03-01)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
od: Lee, J, et al.
Izdano: (2006)

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.
od: Vincent, A, et al.
Izdano: (2003)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
od: McConville, J, et al.
Izdano: (2004)

Clinical and functional characteristics of seronegative and musk myasthenia gravis
od: Huda, S
Izdano: (2017)

Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics
od: Paula Raquel do Vale Pascoal Rodrigues, et al.
Izdano: (2024-01-01)

Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
od: Claudia Vinciguerra, et al.
Izdano: (2023-09-01)

Antibodies to clustered acetylcholine receptor and thymic changes in seronegative myasthenia gravis
od: Leite, M, et al.
Izdano: (2007)

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
od: Leite, M, et al.
Izdano: (2008)

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
od: Damato, V, et al.
Izdano: (2022)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
od: McConville, J, et al.
Izdano: (2002)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
od: Newsom-Davis, J, et al.
Izdano: (2001)

Seronegative Myasthenia Gravis, as a Rare Autoimmune Condition in Turner Syndrome
od: Rimah Sharief, et al.
Izdano: (2017-01-01)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
od: Sun Yong Lee, et al.
Izdano: (2020-05-01)

Myasthenia gravis and other neuromuscular junction disorders.
od: Jacob, S, et al.
Izdano: (2009)

Myasthenia Gravis : Is the Disease Congined to Neuromuscular Junction
od: Ahuja G.K
Izdano: (1999-01-01)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
od: Yeh, J, et al.
Izdano: (2004)

Trauma-Induced Double-Seronegative Ocular Myasthenia Gravis: A Case Report
od: Mohammad Ali Khalid, et al.
Izdano: (2024-06-01)

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
od: Inga Koneczny, et al.
Izdano: (2019-07-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
od: Deymeer, F, et al.
Izdano: (2007)

Myasthenia gravis
od: Vincent, A
Izdano: (2007)

Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation.
od: Spreadbury, I, et al.
Izdano: (2005)

Myasthenia gravis.
od: Vincent, A, et al.
Izdano: (2002)

Myasthenia gravis.
od: Vincent, A, et al.
Izdano: (2004)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
od: Park, K, et al.
Izdano: (2018)

Myasthenia gravis.
od: Vincent, A, et al.
Izdano: (2001)

Severity and Outcome of Myasthenia Gravis
od: J Gordon Millichap
Izdano: (2006-05-01)

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
od: Vincent, A, et al.
Izdano: (2005)

Case report: Coexistence of triple-seronegative myasthenia gravis and pathology-proven cryptogenic organizing pneumonia
od: Shi-Qi Huang, et al.
Izdano: (2023-11-01)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
od: Kee Hong Park, et al.
Izdano: (2018-01-01)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
od: Jacob, S, et al.
Izdano: (2008)

Myasthenia Gravis Presented with Respiratory Failure
od: Vandana Dhangar, et al.
Izdano: (2014-06-01)

Thymomas, myasthenia gravis, associated autoimmune diseases and antibodies against antigens at neuromuscular junction
od: Spalek, P, et al.
Izdano: (2006)

Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis
od: José A. Villegas, et al.
Izdano: (2023-01-01)

Perioperative challenges and neuromuscular blockade concerns in robotic thymectomy for myasthenia gravis
od: Atish Pal, et al.
Izdano: (2020-09-01)

Autoimmune myasthenia gravis.
od: Jayawant, S, et al.
Izdano: (2013)